ZA975767B - Multiphase soft gelatin dosage form - Google Patents

Multiphase soft gelatin dosage form

Info

Publication number
ZA975767B
ZA975767B ZA975767A ZA975767A ZA975767B ZA 975767 B ZA975767 B ZA 975767B ZA 975767 A ZA975767 A ZA 975767A ZA 975767 A ZA975767 A ZA 975767A ZA 975767 B ZA975767 B ZA 975767B
Authority
ZA
South Africa
Prior art keywords
dosage form
soft gelatin
gelatin dosage
multiphase
multiphase soft
Prior art date
Application number
ZA975767A
Other languages
English (en)
Inventor
Michael R Hoy
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of ZA975767B publication Critical patent/ZA975767B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ZA975767A 1996-06-28 1997-06-27 Multiphase soft gelatin dosage form ZA975767B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/671,979 US6024980A (en) 1996-06-28 1996-06-28 Multiphase soft gelatin dosage form

Publications (1)

Publication Number Publication Date
ZA975767B true ZA975767B (en) 1998-12-28

Family

ID=24696660

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA975767A ZA975767B (en) 1996-06-28 1997-06-27 Multiphase soft gelatin dosage form

Country Status (24)

Country Link
US (1) US6024980A (fr)
EP (1) EP0815855B1 (fr)
JP (1) JPH10182437A (fr)
KR (1) KR980000438A (fr)
CN (1) CN1172642A (fr)
AR (1) AR007648A1 (fr)
AT (1) ATE223707T1 (fr)
AU (1) AU2620197A (fr)
BR (1) BR9703771A (fr)
CO (1) CO4900025A1 (fr)
CZ (1) CZ205697A3 (fr)
DE (1) DE69715319T2 (fr)
DK (1) DK0815855T3 (fr)
ES (1) ES2183089T3 (fr)
HU (1) HUP9701113A2 (fr)
ID (1) ID17794A (fr)
IL (1) IL121145A0 (fr)
NO (1) NO972963L (fr)
NZ (1) NZ328182A (fr)
PL (1) PL320815A1 (fr)
PT (1) PT815855E (fr)
SG (1) SG54525A1 (fr)
TN (1) TNSN97111A1 (fr)
ZA (1) ZA975767B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
CA2363842C (fr) 1999-02-26 2006-01-10 Shionogi & Co., Ltd. Capsules molles a croquer presentant des proprietes d'ingestion ameliorees et leur procede de production
US20030060422A1 (en) 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
WO2003024421A2 (fr) * 2001-09-18 2003-03-27 The North West University Forme posologique de triclosan
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
CA2498798A1 (fr) * 2002-09-20 2004-04-01 Alpharma, Inc. Formulation opioides a liberation prolongee et procedes d'utilisation connexes
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
US20040185032A1 (en) * 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US20050249802A1 (en) * 2004-05-06 2005-11-10 The Procter & Gamble Company Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
AU2010300641B2 (en) 2009-09-30 2016-03-17 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
EP2844235A1 (fr) * 2012-04-13 2015-03-11 Banner Pharmacaps, Inc. Capsules molles élastiques contenant des comprimés et remplies de liquides ou de semi-solides et procédés pour leur fabrication
WO2014085599A1 (fr) 2012-11-30 2014-06-05 Acura Pharmaceuticals, Inc. Libération autorégulée de principe pharmaceutique actif
CA2906633C (fr) * 2013-03-15 2021-11-30 Warner Chilcott Company, Llc Forme posologique de capsule de gelatine molle pharmaceutique comportant de la gomme de guar modifie
CA2919892C (fr) 2013-08-12 2019-06-18 Pharmaceutical Manufacturing Research Services, Inc. Comprime extrude anti-abus a liberation immediate
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9616029B2 (en) 2014-03-26 2017-04-11 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release coated reservoir solid dosage form
EP3169315B1 (fr) 2014-07-17 2020-06-24 Pharmaceutical Manufacturing Research Services, Inc. Forme posologique remplie de liquide anti-abus à libération immédiate
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
US11103581B2 (en) 2015-08-31 2021-08-31 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
BR112020016884A2 (pt) * 2018-02-26 2020-12-15 R.P. Scherer Technologies, Llc Forma de dosagem farmacêutica para uma emulsão de simeticona e loperamida
WO2020047205A1 (fr) * 2018-08-31 2020-03-05 Arctic Therapeutics, Llc Nouvelle formulation topique pour application intradermique et utilisations associées

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59131355A (ja) * 1983-01-17 1984-07-28 森下仁丹株式会社 多重軟カプセルの製法
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
EP0211079A4 (fr) * 1985-01-31 1988-02-15 Fujisawa Pharmaceutical Co Capsule souple a cavites multiples; son procede et appareil de fabrication.
JPS61189230A (ja) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd エトポシド製剤
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
US4639846A (en) * 1985-08-16 1987-01-27 Bbc Brown, Boveri & Company, Limited Method and compensating device for compensating current oscillations
US5209978A (en) * 1985-12-26 1993-05-11 Taisho Pharmaceutical Co., Ltd. Seamless soft capsule and production thereof
DE3600084A1 (de) * 1986-01-03 1987-07-09 Scherer Gmbh R P Formkoerper sowie verfahren und vorrichtung zur herstellung eines solchen formkoerpers
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
DE3727894A1 (de) * 1987-08-21 1989-03-02 Stephan Dieter Kapsel fuer pharmazeutisch wirksame inhaltsstoffe einer droge
FR2624012B1 (fr) * 1987-12-07 1991-05-31 Fdb Ste Civile Rech Nouvelles compositions pharmaceutiques a action hypnotique a base d'hydrate de chloral
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5073384A (en) * 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
GB8926612D0 (en) * 1989-11-24 1990-01-17 Erba Farmitalia Pharmaceutical compositions
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
GB9022788D0 (en) * 1990-10-19 1990-12-05 Cortecs Ltd Pharmaceutical formulations
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
US5501857A (en) * 1992-07-24 1996-03-26 Midwestern Bio-Ag Products & Services, Inc. Oral nutritional and dietary composition
US5683716A (en) * 1993-06-30 1997-11-04 Fujisawa Pharmaceutical Co., Ltd. Encapsulated medicine
US5725846A (en) * 1995-03-02 1998-03-10 The Gillette Company Clear antiperspirant stick containing dibenzylidene alditol and hydroxyalkyl cellulose

Also Published As

Publication number Publication date
CN1172642A (zh) 1998-02-11
JPH10182437A (ja) 1998-07-07
DE69715319T2 (de) 2003-01-23
ID17794A (id) 1998-01-29
HUP9701113A2 (hu) 1998-08-28
PL320815A1 (en) 1998-01-05
ES2183089T3 (es) 2003-03-16
NO972963D0 (no) 1997-06-25
CZ205697A3 (cs) 1998-01-14
AU2620197A (en) 1998-01-15
BR9703771A (pt) 1998-09-01
MX9704846A (es) 1998-07-31
HU9701113D0 (en) 1997-08-28
DE69715319D1 (de) 2002-10-17
IL121145A0 (en) 1997-11-20
DK0815855T3 (da) 2003-01-06
NZ328182A (en) 1998-11-25
EP0815855B1 (fr) 2002-09-11
NO972963L (no) 1997-12-29
CO4900025A1 (es) 2000-03-27
TNSN97111A1 (fr) 2005-03-15
US6024980A (en) 2000-02-15
AR007648A1 (es) 1999-11-10
KR980000438A (ko) 1998-03-30
SG54525A1 (en) 1998-11-16
PT815855E (pt) 2003-01-31
ATE223707T1 (de) 2002-09-15
EP0815855A1 (fr) 1998-01-07

Similar Documents

Publication Publication Date Title
SG54525A1 (en) Multiphase soft gelatin dosage form
PL319342A1 (en) Drugs
GB9606805D0 (en) Medicaments
HU9503835D0 (en) Soft gelatin pharmaceutical dosage form
GB9710793D0 (en) Multiphase flowmeter
GB9605293D0 (en) Medicaments
PL322596A1 (en) Antiglucocorticoid drug
PL338781A1 (en) Dosage form
GB9611167D0 (en) Medicaments
GB2331269B (en) Film
GB9718683D0 (en) Novel dosage form
ZA953446B (en) Perhaloalkoxybenzophenone hydrazones
GB9704978D0 (en) Dosage forms
GB9719261D0 (en) Dosage forms
GB9409824D0 (en) Dosage form
GB2329335B (en) Medicament
TW341390U (en) An outlet structure
AU119635S (en) Bowl
PL100884U1 (en) Bowl
GB9420449D0 (en) Processor
GB9705324D0 (en) Medicinal compounds
HUP9903097A3 (en) Medicament containing progestogen-anti-progestogen
ZA947236B (en) Covered bowl
GB0002424D0 (en) Medicament
GB9726234D0 (en) Medicament